Index of 2003 Publications


  1. Gazit A, Yee K, Uecker A, Bohmer FD, Sjoblom T, Ostman A, Waltenberger J, Golomb G, Banai S, Heinrich MC, Levitzki A. Tricyclic quinoxalines as potent kinase inhibitors of PDGFR kinase, Flt3 and Kit.. Bioorg Med Chem. 2003 May;11(9):2007-18.
    PMID: 12670652
    Download PDF

  2. O'Farrell,A.M.; Abrams,T.J.; Yuen,H.A.; Ngai,T.J.; Louie,S.G.; Yee,K.W.H; Wong,W.M.; Lee,L.B.; Town,A.; Smolich,B.D.; Manning,W.C.; Murray,L.J.; Heinrich,M.C.; Cherrington,J.M. SU11248 is a novel FLT3 tyrosine kinase inhibitor with potent activity in vitro and in vivo.Blood 2003.
    Download PDF
    Pub Med ID#12531805

  3. Heinrich,M.C.; Corless,C.L.; Duensing,A.; McGreevey,L.; Chen,C.J.; Joseph,N.; Singer,S.; Griffith,D.J.; Haley,A.; Town,A.; Demetri,G.D.; Fletcher,C.D.M.; Fletcher,J.A. PDGFRA activating mutations in Gastrointestinal Stromal Tumors. Science, Vol 299, Issue 01/31/2003, Page 708
    Download PDF
    Download PDF of Supplemental Materials
    PMID: 1252257

  4. Bauer S, Corless CL, Heinrich MC, Dirsch O, Antoch G, Kanja J, Seeber S, Schütte J. Response to imatinib mesylate of a gastrointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol. 2003 Mar;51(3):261-5
    Download PDF
    PMID: 12655446

  5. Madani A, Kemmer K, Sweeney C, Corless C, Ulbright T, Heinrich M, Einhorn L. Expression of KIT and epidermal growth factor receptor in chemotherapy refractory non-seminomatous germ cell tumors. Ann Oncol. 2003 Jun;14(6):873-80.
    Download PDF
    PMID: 12796025

  6. Heinrich M, Corless C, Demetri G, Blanke C, von Mehren M, Joensuu H, McGreevey L, Chen C, Kiese B, Eisenberg B, Roberts P, Singer S, Fletcher C, Silberman S, Dimitrijevic S, Fletcher J. Kinase mutations and imatinib mesylate response in patients with metastatic gastrointestinal stromal tumor. J Clin Onc 21:4342-4349, 2003.
    Download PDF
    PMID: 14645423

  7. Cruz F III, Rubin B, Wilson D, Town A, Schroeder A, Haley A, Bainbridge T, Heinrich M, Corless C. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res. 2003 Sep 15;63(18):5761-6
    Download PDF
    PMID: 14522897

  8. O'Farrell AM, Foran J, Fiedler W, Serve H, Paquette R, Cooper M, Yuen H, Louie S, Kim H, Nicholas S, Heinrich M, Berdel W, Bello C, Jacobs M, Scigalla P, Manning W, Kelsey S, Cherrington J. An innovative phase I clinical study demonstrates inhibition of FLT3 phosphorylation by SU11248 in acute myeloid leukemia patients.Clin Cancer Res. 2003 Nov 15;9(15):5465-76.
    Download PDF
    PMID: 14654525